Skip to main content

Healthcare Services Group Reports First Quarter Results

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Delivers Strong Revenue, Earnings and Cash Flow

Reiterates 2026 Growth Outlook

  • Revenue of $462.8 million, a 3.4% increase over the prior year.
  • Net income and diluted EPS of $26.1 million and $0.37.
  • Cash flow from operations of $43.7 million; cash flow from operations, excluding the change in payroll accrual, of $23.4 million.
  • Share repurchases of $24.0 million.
  • Reiterates 2026 mid-single-digit revenue growth outlook.

Healthcare Services Group, Inc. (NASDAQ: HCSG) today reported results for the three months ended March 31, 2026.

Ted Wahl, Chief Executive Officer, stated, “We delivered strong first quarter results across revenue, earnings, and cash flow, and we have carried that positive momentum into the second quarter. New client wins and high retention rates drove our year over year topline growth, and our field-based teams’ operational excellence led to quality service outcomes and consistent margins.”

Mr. Wahl continued, “We also returned $24 million of capital through our share repurchase program and ended the quarter with a strong balance sheet and ROIC profile, underscoring our focus on value-creating capital deployment.”

Mr. Wahl concluded, “We are confident that continuing to execute on our strategic priorities, supported by our robust business fundamentals, will enable us to drive growth, while delivering sustainable, profitable results.”

First Quarter Results

  • Revenue was reported at $462.8 million, a 3.4% increase over the prior year.
    • Segment revenues and margins for Environmental and Dietary Services were reported at $208.3 million and 12.1%, and $254.5 million and 9.0%, respectively.
  • Cost of services was reported at $386.9 million or 83.6%.
    • The Company’s goal is to manage cost of services in the 86% range.
  • SG&A was reported at $42.0 million. After adjusting for the $1.6 million decrease in deferred compensation, SG&A was $43.6 million or 9.4%.
    • The Company’s goal is to manage SG&A in the 9.5% to 10.5% range, with the longer term goal of managing those costs into the 8.5% to 9.5% range.
  • Effective tax rate was reported at 24.6%.
    • The Company expects its 2026 effective tax rate to be approximately 25.0%.
  • Net income and diluted EPS were reported at $26.1 million and $0.37.

Balance Sheet and Liquidity

The Company’s primary sources of liquidity are cash flow from operating activities, cash and cash equivalents, and its revolving credit facility. Cash flow from operations was reported at $43.7 million. After adjusting for the $20.3 million increase in the payroll accrual, cash flow from operations was $23.4 million. As of the end of the first quarter, the Company had cash and marketable securities of $214.6 million and an unutilized $300.0 million credit facility.

The Company entered into a Second Amendment, dated April 7, 2026, to its existing Credit Agreement, which provides for a $300.0 million five-year revolving credit facility with an improved SOFR-based pricing grid and enhanced covenant flexibility.

Share Repurchases

In February 2026, the Company announced its plan to further accelerate the pace of its share buybacks and repurchase $75.0 million of its common stock through January 2027. In the first quarter, the Company repurchased $24.0 million of its common stock. The Company has 9.2 million shares remaining under its February 2026 share repurchase authorization.

Conference Call and Upcoming Events

The Company will host a conference call on Wednesday, April 22, 2026, at 8:30 a.m. Eastern Time to discuss its results for the three months ended March 31, 2026. The call may be accessed via phone at 1 (800) 715-9871, Conference ID: 9951274. The call will be simultaneously webcast under the “Events & Presentations” section of the Investor Relations page on the Company’s website, www.hcsg.com. A replay of the webcast will also be available on the website for one year following the date of the earnings call.

The Company will be participating in a Non-Deal Roadshow hosted by William Blair in London, Stockholm and Zurich May 5th through May 7th. The Company will be participating in RBC’s Global Healthcare Conference on May 20th in New York and Benchmark’s Virtual Healthcare House Call Conference on May 28th. In addition, the Company will be participating in Baird’s Global Consumer, Technology and Services Conference on June 3rd in New York.

About Healthcare Services Group, Inc.

Healthcare Services Group (NASDAQ: HCSG) is a leader in managing Environmental and Dietary services within the healthcare industry. With 50 years of experience, HCSG aims to provide improved operational, regulatory, and financial outcomes for its clients.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This release and any schedules incorporated by reference into it may contain forward-looking statements within the meaning of federal securities laws, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as “believes,” “anticipates,” “plans,” “expects,” “estimates,” “will,” “goal,” “intend” and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services to the healthcare industry and primarily providers of long-term care; credit and collection risks associated with the healthcare industry; the impact of bank failures; our claims experience related to workers’ compensation, general liability and other insurance programs; the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; the Company's expectations with respect to selling, general, and administrative expense; the impacts of past or future cyber attacks or breaches; global events including ongoing international conflicts and increased energy prices; and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2025 under “Government Regulation of Customers,” “Service Agreements and Collections,” and “Competition” and under Item 1A. “Risk Factors” in such Form 10-K.

These factors, in addition to delays in payments from customers and/or customers undergoing restructurings, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results have been in the past and could in the future be adversely affected by continued inflation particularly if increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs) cannot be passed on to our customers.

In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies. There can be no assurance that we will be successful in that regard.

USE OF NON-GAAP FINANCIAL INFORMATION

To supplement HCSG’s consolidated financial information, which are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”), the Company believes that certain non-GAAP financial measures are useful in evaluating operating performance and comparing such performance to other companies.

The Company is presenting net cash flow from operations (excluding the impact of payroll accrual), earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA excluding items impacting comparability (“Adjusted EBITDA”). We cannot provide a reconciliation of forward-looking non-GAAP measures to GAAP due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. The presentation of non-GAAP financial measures is not meant to be considered in isolation or as a substitute for financial statements prepared in accordance with GAAP.

HEALTHCARE SERVICES GROUP, INC.

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(in thousands, except per share data)

 

 

For the Three Months Ended

 

March 31,

 

2026

 

2025

Revenue

$

462,766

 

$

447,662

Operating costs and expenses:

 

 

 

Cost of services

 

386,932

 

 

379,691

Selling, general and administrative

 

41,997

 

 

44,966

Income from operations

 

33,837

 

 

23,005

Other income, net

 

703

 

 

889

Income before income taxes

 

34,541

 

 

23,894

 

 

 

 

Income tax provision

 

8,481

 

 

6,666

Net income

$

26,060

 

$

17,228

 

 

 

 

Basic income per common share

$

0.37

 

$

0.23

 

 

 

 

Diluted income per common share

$

0.37

 

$

0.23

 

 

 

 

Basic weighted average number of common shares outstanding

 

69,860

 

 

73,670

 

 

 

 

Diluted weighted average number of common shares outstanding

 

71,049

 

 

73,961

HEALTHCARE SERVICES GROUP, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(in thousands)

 

 

March 31, 2026

 

December 31, 2025

Cash and cash equivalents

$

136,172

 

$

125,189

Restricted cash equivalents

 

97

 

 

5,577

Marketable securities, at fair value

 

42,442

 

 

42,774

Restricted marketable securities, at fair value

 

35,898

 

 

30,352

Accounts receivable, net

 

299,443

 

 

281,303

Notes receivable — short-term, net

 

29,068

 

 

31,243

Other current assets

 

58,110

 

 

59,977

Total current assets

 

601,230

 

 

576,415

 

 

 

 

Property and equipment, net

 

27,032

 

 

27,586

Notes receivable — long-term, net

 

20,628

 

 

25,209

Goodwill

 

79,797

 

 

79,797

Other intangible assets, net

 

6,315

 

 

6,964

Deferred compensation funding

 

52,995

 

 

55,909

Other assets

 

26,848

 

 

22,373

Total assets

$

814,845

 

$

794,253

 

 

 

 

Accrued insurance claims — current

$

22,481

 

$

24,371

Other current liabilities

 

170,885

 

 

146,004

Total current liabilities

 

193,366

 

 

170,375

 

 

 

 

Accrued insurance claims — long-term

 

43,822

 

 

46,142

Deferred compensation liability — long-term

 

52,934

 

 

56,276

Lease liability — long-term

 

9,363

 

 

9,659

Other long-term liabilities

 

1,594

 

 

1,591

 

 

 

 

Stockholders' equity

 

513,766

 

 

510,210

Total liabilities and stockholders' equity

$

814,845

 

$

794,253

HEALTHCARE SERVICES GROUP, INC.

RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES

(Unaudited)

 

Reconciliation of GAAP net income to EBITDA and Adjusted EBITDA (in thousands)

 

For the Three Months Ended

 

March 31,

 

 

2026

 

 

 

2025

 

GAAP net income

 

$

26,060

 

 

$

17,228

 

Income tax provision

 

 

8,481

 

 

 

6,666

 

Interest, net

 

 

(2,256

)

 

 

(2,315

)

Depreciation and amortization(1)

 

 

3,806

 

 

 

3,878

 

EBITDA

 

$

36,091

 

 

$

25,457

 

Share-based compensation

 

 

2,764

 

 

 

3,738

 

Adjusted EBITDA

 

$

38,855

 

 

$

29,195

 

Adjusted EBITDA as a percentage of revenue

 

 

8.4

%

 

 

6.5

%

Reconciliation of GAAP cash flows from operations (excluding the change in payroll accrual)

 

For the Three Months Ended

 

March 31,

 

 

2026

 

 

2025

GAAP cash flows from operations

 

$

43,730

 

 

$

27,501

Accrued payroll(2)

 

 

(20,319

)

 

 

4,591

Cash flows from operations (excluding the change in payroll accrual)

 

$

23,411

 

 

$

32,092

1.

 

Includes right-of-use asset depreciation of $1.9 million and $2.1 million for the three months ended March 31, 2026 and 2025, respectively.

2.

 

The accrued payroll adjustment reflects changes in accrued payroll for the three months ended March 31, 2026 and 2025. The Company processes payroll on set weekly and bi-weekly schedules, and the timing of payments may result in operating cash flow increases or decreases which are not indicative of the Company’s quarterly cash flow performance.

 

Contacts

Company Contacts:
Theodore Wahl
President and Chief Executive Officer

Vikas Singh
Executive Vice President and Chief Financial Officer

Matthew J. McKee
Chief Communications Officer

215-639-4274
investor-relations@hcsgcorp.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.91
+0.00 (0.00%)
AAPL  266.17
+0.00 (0.00%)
AMD  284.49
+0.00 (0.00%)
BAC  53.48
+0.00 (0.00%)
GOOG  330.47
+0.00 (0.00%)
META  668.84
+0.00 (0.00%)
MSFT  424.16
+0.00 (0.00%)
NVDA  199.88
+0.00 (0.00%)
ORCL  181.17
+0.00 (0.00%)
TSLA  386.42
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.